Overview
Biotech
Ibogaine specialist developing treatments for opioid addiction. Founded by Dr. Deborah Mash with 20+ years of ibogaine research. Lead compound DMX-1002 in Phase 1/2a trials.
Visit Website0
Open Roles
Open Positions
No open positions at this time
Clinical Pipeline
No clinical trials on record